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Ischemia-induced neural stem/progenitor cells express
pyramidal cell markers
Martijn Clausena,c, Takayuki Nakagomia, Akiko Nakano-Doia, Orie Sainoa,
Masashi Takataa, Akihiko Taguchib, Paul Luitenc and Tomohiro Matsuyamaa
Adult brain-derived neural stem cells have acquired a lot of
interest as an endurable neuronal cell source that can be
used for central nervous system repair in a wide range of
neurological disorders such as ischemic stroke. Recently,
we identified injury-induced neural stem/progenitor cells in
the poststroke murine cerebral cortex. In this study, we
show that, after differentiation in vitro, injury-induced
neural stem/progenitor cells express pyramidal cell
markers Emx1 and CaMKIIa, as well as mature neuron
markers MAP2 and Tuj1. 5-bromo-2-deoxyuridinine-
positive neurons in the peristroke cortex also express such
pyramidal markers. The presence of newly regenerated
pyramidal neurons in the poststroke brain might provide a
noninvasive therapeutic strategy for stroke treatment with
functional recovery. NeuroReport 22:789–794 c 2011
Wolters Kluwer Health | Lippincott Williams & Wilkins.
NeuroReport 2011, 22:789–794
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Introduction
Stroke is the major cause of death and invalidity in the
western world. Although medical science has made
immense progress in treating the consequences of stroke,
an efficacious therapy to restore lost neural cells is yet to
be conceived. A proposed therapeutic approach is a
supply of neural stem cells (NSCs) to replace the lost
cells in ischemic brain lesions. NSCs have been found in
adult brain aside from the developing brain. Enhancing
this endogenous neurogenesis might provide another
strategy for treating neural loss in the poststroke brain.
Accumulating evidence shows that adult neurogenesis
also takes place outside conventional neurogenic sites
such as the subventricular zone of the lateral ventricle [1]
and the subgranular zone of the hippocampus [2], notably
in the cerebral cortex [3,4], white matter [5], and spinal
cord [6]. Stimulation of endogenous adult NSCs could
contribute to brain function recovery, providing a less
invasive stroke treatment.
Recently, we found that injury/ischemia-induced neural
stem/progenitor cells (iNSPCs) developed in the post-
stroke cortex in adult mice [3]. These cells are capable of
self-renewal and differentiation into electrophysiologi-
cally functional neurons, astrocytes, and myelin-produ-
cing oligodendrocytes. We also showed that iNSPCs
migrated into the peri-infarct area of the poststroke
brain [7], suggesting that iNSPCs contribute to restora-
tive mechanisms of the poststroke brain. Determination
of whether iNSPCs can differentiate into projecting
pyramidal neurons is important for achieving functional
recovery after stroke, as the projecting neurons directly
contribute to the neural circuit that connects physically
separated brain regions.
In this study, we show that ischemia-induced regenera-
tive neurons express the pyramidal cell markers Emx1
and CamKIIa (Ca2+ /calmodulin-dependent kinase IIa),
as well as the nonpyramidal cell marker glutamic acid
decarboxylase (GAD), suggesting iNSPC differentiation
into projecting neurons in the poststroke brain.
Methods
All procedures were carried out under the auspices of the
Animal Care Committee of Hyogo College of Medicine
and were in accordance with the criteria outlined in the
‘Guide for the Care and Use of Laboratory Animals’
prepared by the National Academy of Science.
Induction of permanent ischemia
Six-week-old male CB-17 (CB-17/Icr-+ /+ Jcl) and
SCID (CB-17/Icr-scid/scid Jcl) mice (Clea Japan, Tokyo,
Japan) were subjected to cerebral ischemia. Ligation of
the middle cerebral artery causes highly specific and
reproducible infarction of the ipsilateral cerebral cortex,
as previously described [3]. In brief, the left middle
cerebral artery was electrocauterized and disconnected
just distal to crossing the olfactory tract (distal M1
portion) under halothane anesthesia (2%). The animals
were allowed to rest for 7 days during which powdered
chow and sterilized water were provided ad libitum.
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Cell proliferation assessment
Previously, we demonstrated that immunodeficiency
reduces neural stem/progenitor cell apoptosis and
enhances neurogenesis in the cerebral cortex after
stroke [8]. In this study, to determine cell proliferation
in vivo, 7-week-old male SCID mice were injected with 5-
bromo-2-deoxyuridinine (BrdU) to visualize regenerating
neurons. BrdU (50mg/kg; Sigma-Aldrich, St. Louis,
Missouri, USA) was administered from day 3 after stroke,
three times per week, until the animals were killed on
day 21 after stroke. Thereafter, the mice were strongly
anesthetized using sodium pentobarbital (50mg/kg) and
perfused transcardially with 4% paraformaldehyde. Cor-
onal brain sections (16 mm) were cut on a cryostat,
stained with antibodies for BrdU (1 : 100; Abcam, Cam-
bridge, UK) and Emx1 (1 : 200; Abcam), and visualized
using Alexa-conjugated secondary antibodies (1 : 500;
Alexa Fluor 488 or 555; Invitrogen, Carlsbad, California,
USA). Images of stained sections were assessed using a
fluorescent microscope (Olympus, Tokyo, Japan).
Culturing of neurospheres into pyramidal cells
On day 7 after stroke, infarcted tissue was extracted from
the poststroke cerebral cortex of CB-17 mice as described
before [3]. The ischemic tissue was dissociated into a
single-cell solution. Cells were further cultured into
neurosphere-like cell clusters in Dulbecco’s modified
Eagle’s medium/F12 medium containing endothelial
growth factor (20 nm/ml; Protech, Rocky Hill, New
Jersey, USA), basic fibroblast growth factor (20 ng/ml;
Protech), N2 (1%; Invitrogen), and Y27623 (10 nM; Wako
Pure Chemical Industries Ltd, Osaka, Japan). After
incubation for 21 days, neurospheres were incubated on
poly-L-lysine-coated (0.05%) glass cover slips in neuro-
basal medium (Invitrogen) containing retinoic acid (0.06
mg/ml; Sigma-Aldrich) and B-27 supplement (0.4%;
Sigma-Aldrich). Cell clusters were differentiated for 7
days before being processed further for immunocyto-
chemistry or PCR.
Immunocytochemistry
Differentiated neurosphere-like cell clusters were sub-
jected to immunocytochemistry using antibodies to Tuj1
(1 : 1000; Stemcell Technologies, Vancouver, Canada),
MAP2 (1 : 1000; Convance, Berkeley, California, USA),
CamkIIa (1 : 400; Abcam), and Emx1 (1 : 200; Abcam), as
well as Alexa-conjugated (Alexa Fluor 488 or 555)
secondary antibodies. Nuclei were stained with 40,6-
diamino-2-phenylindole (1 : 1000; Kirkegaard and Perry
Laboratories, Gaithersburg, Maryland, USA).
Reverse transcriptase PCR
Total RNA was extracted from differentiated neuro-
sphere-like cell clusters using an RNeasy Mini-plus kit
(Qiagen, Valencia, California, USA), followed by treat-
ment with DNAse (Qiagen). To compare the pyramidal
markers expressed in regenerated neurons with those in
adult cortical neurons, RNA was extracted from the
nonischemic cortex (contralateral cortex to infarction) of
CB-17 mice. Total RNA (100 ng) was reverse transcribed
under the following conditions: 15 s at 941C, 30 s at 561C,
and 1min at 681C (40 cycles). Primer sequences used
were: CamKIIa forward CCTACACGAAGATGTGCGA
CC and CamKIIa reverse TTGGGAGTGTAGGTGGAC
TA (amplicon size, 163); Emx1 forward primer GCAACC
CCCTCACTCTTTCT and Emx1 reverse primer GCA
ACCCCCTCACTCTTTCT (amplicon size, 380 bp);
Otx1 forward primer Accttcacgcgctcacag and Otx1 reverse
primer GCTCAGAGAGGACGCTGCT (378 bp); and
glyceraldehyde-3-phosphate dehydrogenase forward TGG
TATCGTGGAAGGACTCATGAC and glyceraldehyde-3-
phosphate dehydrogenase reverse ATGCCAGTGAGCT
TCCCGTTCAGC (amplicon size, 180 bp).
Results
BrdU-positive cells express pyramidal cell markers in
the poststroke cortex
We have shown previously that BrdU-positive regenera-
tive neurons are present in the peri-infarct area of the
poststroke cortex [9]. Immunohistochemistry for BrdU
and the pyramidal cell marker Emx revealed that a
number of BrdU-labeled cells were present throughout
the ipsilateral cerebral hemisphere (Fig. 1a–c) on day 21
after stroke; however, they were never seen in the
contralateral side. Some BrdU-labeled cells were identi-
fied simultaneously as being Emx1-positive neurons.
These cells are frequently found in close association
with the infarcted area (peri-infarct area) of the
ipsilateral cortex (Fig. 1b, d–f) and in the ipsilateral
striatum (Fig. 1c, g–i).
Injury-induced neural stem/progenitor cells
differentiate into pyramidal-shaped neurons in vitro
To assess whether iNSPCs are capable of differentiating
into pyramidal neurons in vitro, the nature of cells in
neurosphere-like cell clusters from the ischemic core
after incubation in culture was studied further as
described previously [3,7,9]. Approximately 70%
(68.2±8.1%) of the clusters differentiated into adherent
cells. Cell population analysis for differentiated sphere-
like clusters showed that these cells predominantly
differentiated into neuronal cells and oligodendrocytes
rather than into astrocytes (Tuj-1-positive neuronal cells,
approximately 35%; GFAP-positive astrocytes, approxi-
mately 5%; and O4-positive oligodendrocytes, approxi-
mately 31%) similar to our previous study [3,7,9].
Approximately 6.7% (6.7± 3.1%) of the clusters differ-
entiated into adherent cells characterized by a long apical
dendrite-like structure in their processes (Fig. 1j), which
is positive for the neuron markers Tuj1 and MAP2 (Fig. 1k
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Regenerated neurons and differentiated neural stem/progenitor cells. (a–i), pyramidal Emx1 and 5-bromo-2-deoxyuridinine (BrdU)-positive cells in
the poststroke brain. The postinfarct brain section obtained from mouse 21 days after stroke (a) was subjected to immunohistochemistry for Emx1
and BrdU. Emx1/BrdU double-labeled cells are distributed at the cerebral cortex (b, D–F) and the striatum (c, G–H) around the peri-infarct area.
Higher magnification revealed that the nuclei of Emx1-positive cells were simultaneously labeled by BrdU [(D and G): Emx1; (E and H): BrdU; (F and
I), merged], indicating that Emx1-positive neurons regenerated in the poststroke brain. (j–l): injury-induced neural stem/progenitor cells (iNSPCs)
differentiate into pyramidal-shaped neurons in vitro. Cells in the neurosphere are processed to differentiate into neurons in culture. The adherent cells
appeared pyramidal in shape with a long apical dendrite-like process under a light microscope (j). The pyramidal-shaped cells are Tuj1-positive (k and
l) and MAP2-positive (m and n) neurons, which developed many dendritic spine-like structures in their processes [(k, m, and n): arrows; (l and n):
higher magnification of (k and m), respectively]. These findings suggest that iNSPCs differentiate into pyramidal neurons in vitro. Scale bar: 200mm
(b and c), 50 mm (d–i, k, m), and 100 mm (j).
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and l, Tuj1; m, n, MAP2). These neurons possess short
dentritic spine-like structures (Fig. 1k–n, arrows; Fig. 1l
and n are higher magnification of processes as indicated
in Fig. 1k and m, respectively), suggesting that the
iNSPCs differentiate into pyramidal-shaped neurons.
Injury-induced neural stem/progenitor cell-derived
neurons express both pyramidal and nonpyramidal
markers
To assess whether iNSPCs are capable of differentiating







































































Injury-induced neural stem/progenitor cell (iNSPC)-derived neurons express pyramidal cell markers in vitro. (a–i), The Tuj1-positive neurons with long
processes, which are derived from iNSPCs, express Emx1 in the cell soma [(a), Tuj1; (b), Emx1; (c), merged, arrow]. In contrast, Tuj1-positive neurons
with short processes are negative for Emx1 [(a and c), arrowhead; (d), Tuj1; (e), Emx1; (f), merged], some of which express GAD in the cell soma and
in the processes [(g), Tuj1; (h), GAD; (i), merged, arrows]. (j–l), the neurosphere consisting of iNSPCs cultured in vitro contains cells expressing
MAP2 and CamKIIa after differentiation [(j), CamKIIa; (k), MAP2; (l), merge, arrow]. The long and rather thick dendrite-like processes stained with
MAP2 are developed in radial direction from the neurosphere, suggesting that it predominantly consists of pyramidal neuronal progenitors. Scale bar,
50 mm (a–i) and 200mm (j–l). (m–o) RNA isolated from the cells differentiating in vitro was subjected to PCR for Emx1 (m), Otx1 (m), and CamKIIa
(n). Control RNA was extracted from the intact, nonischemic cortex (contralateral cortex to infarction) of CB-17 mice. Cultured iNSPC-derived
neurons express both Emx1 and CamKIIa, similar to cortical neurons, but they do not express Otx1. The relative expression of pyramidal cell markers
in iNSPC-derived neurons is shown in (o).
792 NeuroReport 2011, Vol 22 No 16
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
was performed for the pyramidal marker Emx1. The cells
differentiating into Tuj-1-positive neurons were simulta-
neously positive for Emx1 (5–7% of cells; Fig. 2a–c,
arrow). However, the majority of neurons positive for Tuj1
were not positive for Emx1 (Fig. 2d–f), suggesting that
these differentiate into both pyramidal and nonpyramidal
neurons. As g-aminobutylic acid neurons are known as
interneurons [10], its synthesizing enzyme GAD was
used as a marker for nonpyramidal neurons. Approxi-
mately 23–26% of cultured cells are GAD positive
(Fig. 2g–i). GAD staining was found primarily to be
present in the axon terminal-like processes and in the cell
bodies of cultured cells (Fig. 2h, arrows). Emx1 staining
was found throughout the whole cell body, with less
staining in nerve cell processes (Fig. 2b). Emx1-positive
cells displayed pyramidal-like morphology, whereas Tuj1-
positive but Emx1-negative neurons showed nonpyrami-
dal morphology (Fig. 2a–c, arrowhead, Fig. 2d–f).
The iNSPCs differentiate into MAP2-positive neurons.
Immunocytochemistry revealed that approximately 6% of
MAP2-positive neurons were positive for CamKIIa. We
could find differentiating neurosphere-like clusters de-
veloping a number of long apical dendrites expressing
MAP2 and staining at the same time for CamKIIa in cell
bodies (Fig. 2j–k, arrow). CamKIIa staining was found
primarily to be present in the cell bodies of cultured cells
(Fig. 2j and l, arrow), whereas MAP2 staining could be
found in the dendrite-like processes and in the cell soma
(Fig. 2k and l). These clusters may consist of pyramidal
neuron/progenitor cells.
Injury-induced neural stem/progenitor cell-derived
neurons express Emx1 and CamKIIa but not Otx1
To confirm the persistent expression of pyramidal
molecular markers, RNA was isolated from the cells
differentiating in vitro and subjected to PCR for
Emx1 [10], Otx1 [11], and CamKIIa [12] (Fig. 2m,
Emx1 and Otx1, n, CamKIIa). The relative expression
levels of neurons differentiated from iNSPCs were
calculated (Fig. 2o). As a result, expression levels of
Emx1 and CamKIIa were similar to those observed in the
intact adult murine cortex (control), but expression levels
of another pyramidal cell marker Otx1 were found to be
significantly lower in iNSPC-derived cells compared with
nonischemic control.
Discussion
This study has shown for the first time the presence of
endogenously regenerating neurons that express several
pyramidal cell markers in the poststroke cortex. Pre-
viously, we found that nestin-positive iNSPCs developed
in the poststroke cortex of the adult murine brain. Such
cells have the capacity for self-renewal and differentiation
into three kinds of neural phenotypes, including neu-
rons [3]. To achieve functional restoration of the
poststroke cortex, lost brain cells need to be replaced
by neurons and by astrocytes and myelin-producing
oligodendrocytes. Moreover, the regenerated neurons
should make synaptic connections with long-distance
connecting neurons to form the neuronal circuit. We
have already shown that iNSPC-derived neurons are
electrophysiologically functional [3]; however, whether
iNSPCs differentiated into pyramidal neurons was not
shown before. As these long-distance spanning neurons
are essential in maintaining cortical functionality, the
regeneration of these particular brain cells is crucial for
functional poststroke recovery.
The current immunohistochemical study showed that the
pyramidal cell marker Emx1 was expressed in regenerat-
ing BrdU-labeled cells after cerebral infarction. Although
Emx1 expression is reported to be especially high in the
developing telencephalic cortex, the expression concurs
with pyramidal cell distribution during their development
and migration from the ventricular zone to the mature
cortex in the adult cortex [10]. In contrast, Emx1 is not
expressed in nonpyramidal cells, where alternatively Lhx6
fulfills a similar function [13]. Thus, involvement of Emx1
in both the developing brain and in cell development in the
adult brain suggests that Emx1 functions as an initiator and
preserver of the cortical neuron phenotype. The expression
of this regulator by BrdU-labeled cells in the poststroke
cortex and cultured neurons derived from cortical iNSPCs
suggest that the adult poststroke cortex is capable of
developing new pyramidal neurons to replace the neurons
lost after cortical ischemia.
This study revealed that CaMKIIa, a multifunctional
kinase, was also expressed in regenerating neurons
differentiated from cortex-derived iNSPCs. The specific
expression in cortical neurons allows CaMKIIa to be used
as a marker for pyramidal cells [12,14]. Although we were
unable to demonstrate CaMKIIa in the poststroke brain
by using the current antibody, the expression of CaMKIIa
by the regenerated neurons was confirmed both by in-
vitro immunocytochemistry and by PCR. In such in-vitro
conditions, we revealed CamKIIa immunoreactivity to be
localized in the neural soma of cultured neurons. It was
reported previously that CaMKIIa located in postsynaptic
sites of mature neurons plays a crucial role in synaptic
plasticity through postsynaptic a-amino-3-hydroxy-5-
methylisoxazole-4-propionate receptors and N-methyl-D-
aspartic acid receptors [12]. As CaMKIIa is activated by
elevated intracellular Ca2+, which causes calmodulin
binding to CaMKIIa, the current finding may suggest
that inactive CaMKIIa resides before calmodulin activa-
tion and transportation to the postsynaptic sites [15].
In this study, we performed PCR by using the RNA
extracted from differentiating cultured neurons but not
from the poststroke brain, which may contain the
resident pyramidal neurons surviving after ischemic
insult. PCR for Emx1 and CaMKIIa on mRNA showed
that the expression levels of these genetic markers were
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found to be comparable to the expression range in the
nonischemic adult cortex. However, expression levels of
another pyramidal marker, Otx1, were found to be di-
minished in the same cell clusters. Otx1 is a transcription
factor involved in telencephalon development and is
especially highly expressed in layer-5 neurons that project
to subcortical targets [16]. However, a previous report has
shown that embryonic stem (ES)-derived neurons never
express Otx1, although they appear to differentiate into
fully functioning pyramidal neurons that integrate into
the adult murine brain [11], suggesting that Otx1 is not
essential in cortical neuronal development.
Stem cells have been regarded as a possible therapeutic
tool for various pathologies. Both adult and ES cell-derived
NSCs [17–20] are regarded as cell sources that can be used
to restore crucial brain cells that were lost. A number of
studies and the current study have shown that NSCs
differentiate into a wide variety of neuronal subtypes and
glia cells. However, the projecting pyramidal cortical
neurons forming long-distance neuronal circuitry have been
derived from these progenitor cells without much success,
although a recent publication has demonstrated that ES
cell-derived NSCs can differentiate into pyramidal cells
that integrate into the adult poststroke cortex [11].
Although it would still be challenging to accomplish cortical
neurogenesis after permanent ischemic stroke in vivo, we
have shown that adequate support of iNSPCs in the in-vivo
environment of the poststroke cortex (e.g., regulation of
endothelial cells [7,9] and inflammatory cells [8]) could
promote the proliferation of iNSPCs and enhance neuro-
genesis and cortical functional recovery.
Conclusion
This study showing that iNSPCs can differentiate into
pyramidal neurons provides the possibility of cortical
neurogenesis with functional recovery in the ischemic
human brain through the regulation of iNSPCs, because
our recent study has shown that iNSPCs are also present in
the poststroke human cortex [21]. Further studies for their
N-methyl-D-aspartic acid-induced glutamatergic response
and morphological connectivity to distant regions are needed
to confirm the regeneration of functional projecting neurons.
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